StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report report published on Sunday morning. The firm issued a sell rating on the stock.
SenesTech Stock Performance
Shares of NASDAQ SNES opened at $2.90 on Friday. The firm’s 50 day moving average price is $3.74 and its 200-day moving average price is $5.83. SenesTech has a 52-week low of $1.90 and a 52-week high of $78.00. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05.
SenesTech (NASDAQ:SNES – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The company reported ($3.08) earnings per share for the quarter, beating the consensus estimate of ($3.20) by $0.12. SenesTech had a negative net margin of 464.09% and a negative return on equity of 168.64%. The firm had revenue of $0.46 million during the quarter, compared to analysts’ expectations of $0.49 million. During the same period in the previous year, the company earned ($84.03) earnings per share.
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- 3 REITs to Buy and Hold for the Long Term
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Top Stocks Investing in 5G Technology
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is the Nikkei 225 index?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
